Path Traversal Vulnerability in ZKTeco BioTime Product
CVE-2023-38951

9.8CRITICAL

Key Information:

Vendor

Zkteco

Status
Biotime
Vendor
CVE Published:
3 August 2023

What is CVE-2023-38951?

A path traversal vulnerability exists in ZKTeco's BioTime v8.5.5, which enables attackers to bypass directory restrictions and manipulate file paths. This weakness is exploited through a malicious SFTP configuration, allowing unauthorized users to write arbitrary files to the server, potentially leading to data breaches or further compromise of the system.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

References

https://claroty.com/team82/disclosure-dashboard/cve-2023-...
https://github.com/omair2084/biotime-rce-8.5.5/blob/main/...
https://krashconsulting.com/fury-of-fingers-biotime-rce/

EPSS Score

10% chance of being exploited in the next 30 days.

CVSS V3.1

Score:
9.8
Severity:
CRITICAL
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.